JYLAMVO
- Product NDC
- 81927-204
- 11-digit product format
- 819270204
- Labeler code
- 81927
- Product ID
- 81927-204_3a5966e9-256b-4595-b962-e00d07526623
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Methotrexate
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- SHORLA ONCOLOGY INC.
- Application
- NDA212479
- Marketing category
- NDA
- Marketing start
- 2023-12-15
- Substance
- METHOTREXATE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- JYLAMVO
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| METHOTREXATE | 2 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | YL5FZ2Y5U1 |
| Rxcui | 2671456, 2671462 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 81927-204-01 | JYLAMVO | 1 in 1 CARTON | SOLUTION | 1 | | 10 |
| 81927-204-01 | JYLAMVO | 60 mL in 1 BOTTLE, GLASS | SOLUTION | 60 | | 10 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 81927-204 | JYLAMVO (METHOTREXATE) SOLUTION [SHORLA ONCOLOGY INC.] | 9 | Current NDC, 2 package rows | 20250502_96e931f5-51ae-4bdf-a441-bb0dd26d4c0e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 81927-204-01 | 81927020401 | 1 BOTTLE, GLASS in 1 CARTON (81927-204-01) / 60 mL in 1 BOTTLE, GLASS | 2023-12-15 | No | No | Historical |